5630-53-5
- Product Name:Tibolone
- Molecular Formula:C21H28O2
- Purity:99%
- Molecular Weight:312.452
Product Details;
CasNo: 5630-53-5
Molecular Formula: C21H28O2
Appearance: white solid
Medical Intermediate Tibolone 5630-53-5 In Medicine Chinese GMP Manufacturer
- Molecular Formula:C21H28O2
- Molecular Weight:312.452
- Appearance/Colour:white solid
- Vapor Pressure:6.96E-10mmHg at 25°C
- Melting Point:169 °C
- Refractive Index:105 ° (C=0.54, CH2Cl2/Et2O)
- Boiling Point:447.4 °C at 760 mmHg
- PKA:13.10±0.60(Predicted)
- Flash Point:190.6 °C
- PSA:37.30000
- Density:1.13 g/cm3
- LogP:3.88260
Tibolone(Cas 5630-53-5) Usage
Description |
Tibolone is a synthetic steroid with weak progestational and estrogenic properties, reportedly useful in controlling symptoms resulting from natural or surgical menopause. It has thus far shown no significant antithrombotic effect in post-menopausal patients. |
Chemical Properties |
White Solid |
Originator |
Akzo (Organon) (The Netherklands) |
Uses |
A synthetic steroid with weak estrogenic, androgenic and progestogenic activity. A pharamceutical used in the treatment of menopausal syndrome |
Definition |
ChEBI: Estran-3-one with a double bond between positions 5 and 10, and bearing both an ethynyl group and a hydroxy group at position 17 (R-configuration). A synthetic steroid hormone drug which acts as an agonist at all five type I steroid hormon receptors, it is used in the prevention of postmenopausal osteoporosis and for treatment of endometriosis. |
Brand name |
Livial |
Pharmacokinetics |
Raloxifene is rapidly absorbed following oral administration, with an estimated 60% absorption, but it has a very low bioavailability (2%), associated with extensive phase II metabolism. The metabolites are excreted via the bile, with potential enterohepatic recycling that could account for the interaction with cholestyramine. Supportive of the enterohepatic recycling is the half-life of 28 hours. Metabolism of raloxifene occurs to a great extent in the intestine and consists of glucuronide conjugation catalyzed by uridine diphosphate glucuronosyltransferase (UGT). |
Clinical Use |
Tibolone is a synthetic steroid that has been shown to increase bone mineral density similar to alendronate. The U.S. FDA approval is pending; overseas, this agent is used for the treatment of menopausal symptoms as well as the prevention of osteoporosis. It is considered to be a viable alternative to conjugated equine estrogen plus micronized progesterone. |
Side effects |
The most common reason for patient withdrawal from clinical trials was vaginal bleeding (also a common side effect when estrogen therapy is used). |
InChI:InChI=1/C21H28O2/c1-4-21(23)10-8-18-19-13(2)11-14-12-15(22)5-6-16(14)17(19)7-9-20(18,21)3/h1,13,17-19,23H,5-12H2,2-3H3/t13-,17-,18+,19-,20+,21+/m1/s1
5630-53-5 Relevant articles
Preparation method of tibolone
-
Paragraph 0034; 0037-0038; 0041-0042; 0045-0046; 0049, (2020/11/25)
The invention discloses a preparation me...
Synthetic method of tibolone
-
, (2020/05/01)
The intention relates to a synthesis met...
FLUORESCENCE BASED DETECTION OF SUBSTANCES
-
, (2009/09/28)
A method for the fluorescent detection o...
PROCESS FOR THE PREPARATION OF PURE CRYSTALLINE TIBOLONE
-
Page/Page column 4-9, (2008/06/13)
There is disclosed a process for the pre...
5630-53-5 Process route
- 15506-05-5
3-Methoxy-7α-methyl-17α-aethinyl-17β-hydroxy-Δ2,5(10)-19-norandrastadien
- 5630-53-5
tibolone
Conditions | Yield |
---|---|
3-Methoxy-7α-methyl-17α-aethinyl-17β-hydroxy-Δ2,5(10)-19-norandrastadien; With ascorbic acid; In ethanol; at 20 - 30 ℃; for 1h; Activated Carbon Darco G60;
With hydrogenchloride; In ethanol; water; at 20 - 25 ℃;
|
78% |
With oxalic acid; In methanol;
|
-
C25H36O4
- 5630-53-5
tibolone
Conditions | Yield |
---|---|
With sulfuric acid; In water; acetone; at 0 - 5 ℃; for 1h; Industrial scale;
|
90% |
5630-53-5 Upstream products
-
105186-33-2
3,3-dimethoxy-7α-methyl-19-nor-17α-pregn-5(10)-en-20-yn-17β-ol
-
15506-05-5
3-Methoxy-7α-methyl-17α-aethinyl-17β-hydroxy-Δ2,5(10)-19-norandrastadien
-
105186-32-1
7α-methylestr-5(10)-ene-3,17-dione
-
88247-84-1
3,3-dimethoxy-7α-methylestr-5(10)-en-17-one
5630-53-5 Downstream products
-
105186-34-3
10β-hydroperoxy-17β-hydroxy-7α-methyl-19-nor-17α-pregn-4-en-20-yn-3-one
-
100239-44-9
3alpha-Hydroxytibolone
-
100239-45-0
(3β,7α,17α)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3,17-diol
-
105186-35-4
10β,17β-dihydroxy-7α-methyl-19-nor-17α-pregn-4-en-20-yn-3-one
Relevant Products
-
Isomaltitol
CAS:534-73-6
-
Acetylsalicylic acid
CAS:50-78-2
-
4-Methyl-2-hexanamine hydrochloride
CAS:13803-74-2